
David Fudman, MD
@fudmanmd
Gastroenterologist with focus on #IBD and quality improvement @UTSWmedcenter (Tweets mine, not medical advice, of course)
ID: 1098062521049714688
https://profiles.utsouthwestern.edu/profile/95363/david-fudman.html 20-02-2019 03:31:20
1,1K Tweet
1,1K Followers
571 Following



‼️Important HBV reaction prevention in IBD pts. Note JAKi mod risk > aTNF in sAg(-), cAb(+) -> antiviral ppx. Shubha Bhat, PharmD Jana G Hashash, MD, MSc David Fudman, MD Waseem Ahmed David Choi, PharmD gastrojournal.org/article/S0016-…


🚨Don't miss the 2025 UTSW What's New in GI symposium! 🔥Tyler Berzin MD, FASGE keynote: Navigating the ‘Jagged Edge’ of AI (ethics credit!) 💊IBD therapy updates galore 🔼GJOO, refractory GERD & more foregut tips 📏New endo metrics, video cases ➕more! Register: bit.ly/3PNhf77


Thrilled to welcome Tyler Berzin MD, FASGE to the 2025 UT Southwestern What’s New in GI conference Just getting started teaching us to “navigate the jagged edge” of AI in GI


UT Southwestern Medical Center’s What’s New in GI 2025 was a great success with talks from Shawn Shah, Kerry Dunbar, MD, PhD, David Fudman, MD, Daniel Ellis, Tom Tielleman, MD, Tarek Sawas, MD, MPH, and many more! The highlight was a fantastic keynote talk on AI from Tyler Berzin MD, FASGE visiting from BIDMC Department of Medicine!


Thanks to the whole team at UTSW Gastroenterology Fellowship for a great conference in Dallas this weekend. You have an incredible group of faculty and fellows, and it was great to catch up wtih David Fudman, MD, Tom Tielleman, MD, and many others.

Exciting news! The Helmsley Charitable Trust awarded $4 million to the Foundation to advance remission strategies for IBD. The grant will support implementing a treat-to-target approach in clinical practice, aiming to improve patient outcomes! bit.ly/41dyWCb


1) 🚨 THREAD: The questions about #Measles have started. Here's what we know about the current outbreak. Crohn's & Colitis Foundation American Gastroenterological Association (AGA) ACG AASLD. Texas Society for Gastroenterology and Endoscopy Bincy Abraham, MD, MS cdc.gov/measles/data-r…

#MondayNightIBD 1/Let’s talk about the🆕 MOA in the #IBD 🧰: anti-#IL23p19 ✅New trial designs 🔖Placebo group in maintenance received drug during induction (interpret📊accordingly) ✅High efficacy & safety ✅Effective in bio-naive & -exposed 🤿Let’s dive into Miri, Gus, Risa in UC & CD !



Read the paper by Singh et al on "Treat-to-target of endoscopic remission in patients with inflammatory bowel disease in symptomatic remission on advanced therapies (QUOTIENT)..." via bit.ly/44m1xrZ @davidhudesmanMD Dana Lukin MD, PhD Tauseef Ali MD, FACG AGAF FACP Vipul Jairath MBChB DPhil #IBD


👋Join us at Advances in IBD Regionals in Dallas Essential updates, new therapies, and case discussions with (much more) expert faculty! Register: aibdregionals.com/rates @IBDConference Tauseef Ali MD, FACG AGAF FACP Christina Ha MD Raymond Cross Maia Kayal MD Bincy Abraham, MD, MS #AIBDREGIONALS


#MondayNightIBD Aline Charabaty, MD, FACG, AGAF 55M w/ UC x30y. Prior 5-ASA, 6MP. On IFX 5 mg/kg q8w x5y. Mild UC sx before infusions. 🔦Last scope 1y ago: Mayo 0. Now FCP 141, IFX level 3. New dx: metastatic melanoma → onc is starting nivolumab. What do you recommend for his UC?


Taha Qazi SandraQuezadaMD David T. Rubin, MD Can’t wait to learn from everyone ! 🌟 agenda with some of my fav 💎 people in IBD ! Thank you for the invite !


What a pleasure to have you Bincy Abraham, MD, MS ! Thanks for making the cross state journey 😃